A Study of Rilvegostomig Plus Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection
Clinicaltrials.gov ID
NCT06109779
Status
Recruiting
Study Type
Interventional, Phase 3
Sponsor
AstraZeneca
Start Date
8 décembre 2023
Anticipated End Date
30 juin 2029
Study Contact
Name: AstraZeneca Clinical Study Information Center
Phone Number: 1-877-240-9479
Email: information.center@astrazeneca.com
About the Study
A global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator's choice of chemotherapy in participants with BTC after surgical resection with curative intent.
Conditions
Biliary Tract Cancer
Inclusion/Exclusion Criteria?
Primary, Secondary, Other Outcome Measures??
Locations in Canada
BC Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada
Nova Scotia Health Authority/QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 2Y9, Canada
Kingston Health Sciences Centre, Kingston, Ontario, K7L 5P9, Canada
The Ottawa Hospital, Ottawa, Ontario, K1H 8L6, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada
McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada
About the Study
A global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator's choice of chemotherapy in participants with BTC after surgical resection with curative intent.
Conditions
Biliary Tract Cancer
Interventions
DRUG:
Rilvegostomig
Capecitabine
Gemcitabine/Cisplatin
S-1 [Tegafur/Oteracil/gimeracil]
Locations in Canada
BC Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada
Nova Scotia Health Authority/QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 2Y9, Canada
Kingston Health Sciences Centre, Kingston, Ontario, K7L 5P9, Canada
The Ottawa Hospital, Ottawa, Ontario, K1H 8L6, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada
McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada